ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/12/14 | 3,305 | 3,345 | 3,300 | 3,320 | +10 | +0.3% | 83,900 |
2021/12/13 | 3,345 | 3,355 | 3,290 | 3,310 | -30 | -0.9% | 91,200 |
2021/12/10 | 3,385 | 3,390 | 3,330 | 3,340 | -45 | -1.3% | 121,200 |
2021/12/09 | 3,390 | 3,410 | 3,365 | 3,385 | -5 | -0.1% | 71,200 |
2021/12/08 | 3,395 | 3,420 | 3,380 | 3,390 | +10 | +0.3% | 86,300 |
2021/12/07 | 3,275 | 3,395 | 3,270 | 3,380 | +110 | +3.4% | 113,000 |
2021/12/06 | 3,305 | 3,355 | 3,265 | 3,270 | -20 | -0.6% | 76,200 |
2021/12/03 | 3,185 | 3,295 | 3,155 | 3,290 | +85 | +2.7% | 100,800 |
2021/12/02 | 3,205 | 3,245 | 3,200 | 3,205 | -40 | -1.2% | 139,400 |
2021/12/01 | 3,235 | 3,280 | 3,220 | 3,245 | +10 | +0.3% | 131,400 |
2021/11/30 | 3,305 | 3,350 | 3,235 | 3,235 | -70 | -2.1% | 256,200 |
2021/11/29 | 3,365 | 3,365 | 3,295 | 3,305 | -90 | -2.7% | 112,500 |
2021/11/26 | 3,485 | 3,485 | 3,380 | 3,395 | -110 | -3.1% | 81,100 |
2021/11/25 | 3,530 | 3,545 | 3,500 | 3,505 | -10 | -0.3% | 58,600 |
2021/11/24 | 3,510 | 3,560 | 3,495 | 3,515 | -15 | -0.4% | 90,700 |
2021/11/22 | 3,505 | 3,545 | 3,495 | 3,530 | +25 | +0.7% | 95,700 |
2021/11/19 | 3,545 | 3,545 | 3,485 | 3,505 | -45 | -1.3% | 108,200 |
2021/11/18 | 3,585 | 3,605 | 3,530 | 3,550 | -75 | -2.1% | 146,200 |
2021/11/17 | 3,635 | 3,670 | 3,615 | 3,625 | -20 | -0.5% | 164,800 |
2021/11/16 | 3,690 | 3,700 | 3,645 | 3,645 | -50 | -1.4% | 58,300 |
2021/11/15 | 3,685 | 3,715 | 3,670 | 3,695 | +50 | +1.4% | 85,100 |
2021/11/12 | 3,575 | 3,660 | 3,575 | 3,645 | +55 | +1.5% | 92,400 |
2021/11/11 | 3,595 | 3,635 | 3,575 | 3,590 | +15 | +0.4% | 99,400 |
2021/11/10 | 3,575 | 3,605 | 3,560 | 3,575 | +25 | +0.7% | 78,300 |
2021/11/09 | 3,660 | 3,670 | 3,550 | 3,550 | -55 | -1.5% | 108,400 |
2021/11/08 | 3,680 | 3,750 | 3,565 | 3,605 | -50 | -1.4% | 166,500 |
2021/11/05 | 3,605 | 3,660 | 3,605 | 3,655 | +10 | +0.3% | 100,100 |
2021/11/04 | 3,710 | 3,710 | 3,605 | 3,645 | -10 | -0.3% | 108,700 |
2021/11/02 | 3,650 | 3,675 | 3,635 | 3,655 | -30 | -0.8% | 118,400 |
2021/11/01 | 3,600 | 3,690 | 3,595 | 3,685 | +145 | +4.1% | 146,900 |
2021/10/29 | 3,510 | 3,545 | 3,450 | 3,540 | +45 | +1.3% | 148,700 |
2021/10/28 | 3,525 | 3,525 | 3,465 | 3,495 | -40 | -1.1% | 554,100 |
2021/10/27 | 3,555 | 3,555 | 3,505 | 3,535 | +10 | +0.3% | 141,200 |
2021/10/26 | 3,535 | 3,535 | 3,485 | 3,525 | -10 | -0.3% | 146,000 |
2021/10/25 | 3,535 | 3,580 | 3,535 | 3,535 | -5 | -0.1% | 195,200 |
2021/10/22 | 3,500 | 3,560 | 3,490 | 3,540 | +40 | +1.1% | 148,600 |
2021/10/21 | 3,515 | 3,565 | 3,500 | 3,500 | -25 | -0.7% | 101,600 |
2021/10/20 | 3,510 | 3,550 | 3,505 | 3,525 | +45 | +1.3% | 149,900 |
2021/10/19 | 3,450 | 3,485 | 3,435 | 3,480 | +40 | +1.2% | 70,600 |
2021/10/18 | 3,490 | 3,490 | 3,430 | 3,440 | -50 | -1.4% | 116,900 |
2021/10/15 | 3,425 | 3,490 | 3,425 | 3,490 | +65 | +1.9% | 90,000 |
2021/10/14 | 3,380 | 3,425 | 3,380 | 3,425 | +40 | +1.2% | 84,700 |
2021/10/13 | 3,395 | 3,410 | 3,360 | 3,385 | +20 | +0.6% | 128,600 |
2021/10/12 | 3,400 | 3,410 | 3,355 | 3,365 | -70 | -2% | 110,300 |
2021/10/11 | 3,440 | 3,460 | 3,410 | 3,435 | -5 | -0.1% | 104,200 |
2021/10/08 | 3,390 | 3,460 | 3,375 | 3,440 | +15 | +0.4% | 190,500 |
2021/10/07 | 3,460 | 3,475 | 3,425 | 3,425 | -40 | -1.2% | 91,500 |
2021/10/06 | 3,420 | 3,490 | 3,420 | 3,465 | +35 | +1% | 116,200 |
2021/10/05 | 3,490 | 3,500 | 3,415 | 3,430 | -85 | -2.4% | 116,000 |
2021/10/04 | 3,575 | 3,575 | 3,495 | 3,515 | -5 | -0.1% | 107,400 |
851~
900
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 407,800円 | +5.8% | +1.2% | 2.94% | 13.52倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム